The majority (60–80%) of the patients with family hyperlipidemia (FH) harbor mutations in the LDLR gene [13], but apoE serves as a major member of many ligands of LDLR which can transport plasma chylomicrons and VLDL cholesterol to the liver for metabolism by LDL receptor and related receptors. Here, LDLR is linked to familial hyperaldosteronism.